TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease
about
TACI is a TRAF-interacting receptor for TALL-1, a tumor necrosis factor family member involved in B cell regulationTumor necrosis factor (TNF) receptor superfamily member TACI is a high affinity receptor for TNF family members APRIL and BLySImpaired IgA class switching in APRIL-deficient miceBiologically active APRIL is secreted following intracellular processing in the Golgi apparatus by furin convertaseAPRIL modulates B and T cell immunityAtacicept: targeting B cells in multiple sclerosisGraft-versus-tumor response in patients with multiple myeloma is associated with antibody response to BCMA, a plasma-cell membrane receptorThe regulation of T cell homeostasis and autoimmunity by T cell-derived LIGHTModulation of T-cell responses to alloantigens by TR6/DcR3The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the gamesThe current status of targeting BAFF/BLyS for autoimmune diseasesSLE--systemic lupus erythematosus: a BLySful, yet BAFFling, disorderB cells, BAFF/zTNF4, TACI, and systemic lupus erythematosus.Natural antisense RNA inhibits the expression of BCMA, a tumour necrosis factor receptor homologue.Current and emerging treatment options in the management of lupusExploring BAFF: its expression, receptors and contribution to the immunopathogenesis of Sjögren's syndromeKey issues in the management of patients with systemic lupus erythematosus: latest developments and clinical implicationsB-cell survival factors in autoimmune rheumatic disordersScanning for Therapeutic Targets within the Cytokine Network of Idiopathic Inflammatory MyopathiesRole of Tumor Necrosis Factor Superfamily in Neuroinflammation and AutoimmunityThe B-cell receptor orchestrates environment-mediated lymphoma survival and drug resistance in B-cell malignanciesThe rationale for BAFF inhibition in systemic lupus erythematosusProfile of atacicept and its potential in the treatment of systemic lupus erythematosusRole of type I interferons in the activation of autoreactive B cellsEffect of TACI signaling on humoral immunity and autoimmune diseasesThe antigen presenting cells instruct plasma cell differentiationNon-Canonical NF-κB Signaling Initiated by BAFF Influences B Cell Biology at Multiple JuncturesLigand-receptor binding revealed by the TNF family member TALL-1Targeting dendritic cell function during systemic autoimmunity to restore toleranceFollicular Helper T Cells in Systemic Lupus Erythematosus: Why Should They Be Considered as Interesting Therapeutic Targets?Modelling clinical systemic lupus erythematosus: similarities, differences and success storiesMarginal-zone B cellsSINK is a p65-interacting negative regulator of NF-kappaB-dependent transcriptionB lymphocyte stimulator (BLyS): a therapeutic trichotomy for the treatment of B lymphocyte diseasesDCs induce CD40-independent immunoglobulin class switching through BLyS and APRILB cell activation factor (BAFF) is a novel adipokine that links obesity and inflammationInterleukin 31, a cytokine produced by activated T cells, induces dermatitis in miceA therapeutic role for BLyS antagonistsA soluble BAFF antagonist, BR3-Fc, decreases peripheral blood B cells and lymphoid tissue marginal zone and follicular B cells in cynomolgus monkeysEnhanced B cell expansion, survival, and humoral responses by targeting death receptor 6
P2860
Q22254448-0DB293E5-2DD8-4BCC-B019-70E79210BDF0Q24290135-2F2A0AA2-ADD3-4D3D-9633-63154F91E3EBQ24313032-94CC0903-1214-4F45-936E-4C7D35AA0237Q24522584-565EDF7B-A5EF-4FB7-84F2-DC17CD7A602BQ24552299-4D2035FC-DB6E-4B3E-A3CA-588ABA839239Q24628925-8AFE74D6-DA02-4E96-B4B6-952092D90266Q24670205-CAC42C09-B8A0-4B60-AC47-9D41C984C852Q24670612-FE3CAF31-635C-4214-8551-9817B275DD02Q24672018-C7C74FE8-34BF-4AB4-B7FB-6A88B2C69ED6Q24683018-F92C1D65-366F-49BA-B2A0-F7EE0D7B25C1Q24796930-D4B52F92-6DD2-415F-B7EF-36D52C6FBF94Q24804613-98D3E5A4-5015-43D8-AFF3-36838434DF3CQ24805469-42CA644F-DA12-4C23-8E25-B98BC35C77A4Q24806909-F96EF5A0-3874-46C6-AD7A-BF6CC5F6FA5EQ26741266-DF9F3F39-CDEC-422D-AD29-30AB8CE82D13Q26770648-4B0E741C-F700-4DB8-A29F-954BAA868C3DQ26775756-6B86C23A-A43E-400C-8FDD-F3186CC59B3AQ26796484-D47814AE-B30F-4A49-AA15-997C85CFAC37Q26798209-188DCC92-E0EB-4E0E-BB6E-D41463BC023FQ26800155-4D0688BF-F01D-43C8-BAEB-5F6995A87E3CQ26822700-F59D4220-BB0D-4A00-BA81-684535BA48C4Q26827373-AD7F0B3B-C122-43D7-B69B-DF521C27CA51Q26849719-F3937D5B-83A4-44D6-814D-7537DCF97D8AQ26858821-B9659AD2-A398-4896-A0EE-0E674E9FA694Q26995571-D2BF85E6-0016-419B-BCAF-689A6F183B95Q26995780-FC30E183-F6D1-469F-A58A-927C22736AA1Q27024640-C5E819CF-CC05-44AF-9FDB-9CC3BF5710CCQ27641102-5381AF1C-08C5-48CA-8F36-DAA4AC2F03DEQ27687098-53069EDE-2A94-4A1A-A918-9E5371B91835Q28067781-D5E6ACFC-CC84-4CAF-9611-2214871A4C13Q28074217-9BFABA51-5751-455F-B869-7B6374FC6AE9Q28201000-A38E796A-8316-4409-9AED-39AF8765D283Q28203033-97CB8CC8-DA12-4A18-B9AA-65874F73109EQ28208717-1578DE19-C06D-4E0D-98D8-9D0F84767B5DQ28216755-CFDE45DC-7C18-4592-8C79-F2CAF2CDF0A7Q28238437-33127458-53FE-4D33-83FF-FB16773C75D4Q28265772-D470A28B-EAFB-4F73-B3EA-CFDCE768734AQ28269809-02E92C1F-3176-4895-9122-0E397F93D76AQ28293722-E1FE68DC-09EB-4E42-A8FC-6B234298B039Q28509905-9377AA4B-8CDD-4519-B3ED-89C44F6FEB60
P2860
TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease
@ast
TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease
@en
TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease
@en-gb
TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease
@nl
type
label
TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease
@ast
TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease
@en
TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease
@en-gb
TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease
@nl
prefLabel
TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease
@ast
TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease
@en
TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease
@en-gb
TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease
@nl
P2093
P3181
P356
P1433
P1476
TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease
@en
P2093
A Grossman
C Lofton-Day
H Blumberg
J Johnston
J Parrish-Novak
P2888
P3181
P356
10.1038/35010115
P407
P577
2000-04-27T00:00:00Z
P6179
1021276220